Bio-Techne

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Bio-Techne and other ETFs, options, and stocks.

About TECH

Bio-Techne Corp. is a global life sciences company providing innovative tools and bioactive reagents for research and clinical diagnostic communities. The firm's products assist scientific investigations into biological processes and the nature and progress of specific diseases. 

CEO
Kim Kelderman
CEOKim Kelderman
Employees
3,000
Employees3,000
Headquarters
Minneapolis, Minnesota
HeadquartersMinneapolis, Minnesota
Founded
1976
Founded1976
Employees
3,000
Employees3,000

TECH Key Statistics

Market cap
11.36B
Market cap11.36B
Price-Earnings ratio
62.57
Price-Earnings ratio62.57
Dividend yield
0.44%
Dividend yield0.44%
Average volume
3.60M
Average volume3.60M
High today
$72.54
High today$72.54
Low today
$72.38
Low today$72.38
Open price
$72.50
Open price$72.50
Volume
2.65M
Volume2.65M
52 Week high
$72.69
52 Week high$72.69
52 Week low
$43.20
52 Week low$43.20

Stock Snapshot

As of today, Bio-Techne(TECH) shares are valued at $72.40. The company's market cap stands at 11.36B, with a P/E ratio of 62.57 and a dividend yield of 0.44%.

On 2026-10-01, Bio-Techne(TECH) stock traded between a low of $72.38 and a high of $72.54. Shares are currently priced at $72.40, which is +0.0% above the low and -0.2% below the high.

Bio-Techne(TECH) shares are trading with a volume of 2.65M, against a daily average of 3.6M.

During the past year, Bio-Techne(TECH) stock moved between $43.20 at its lowest and $72.69 at its peak.

During the past year, Bio-Techne(TECH) stock moved between $43.20 at its lowest and $72.69 at its peak.

TECH News

Simply Wall St 3h
What Bio-Techne Investors Were Actually Arguing About

For Bio-Techne shareholders, the return from the start of the year was 22.0%, including dividends. That outcome now sits alongside a late-2026 takeover agreemen...

What Bio-Techne Investors Were Actually Arguing About
Benzinga 6d
Robert V Baumgartner Exercises Options, Realizes $754K - Benzinga

...

Robert V Baumgartner Exercises Options, Realizes $754K - Benzinga

Analyst ratings

100%

of 14 ratings
Buy
0%
Hold
100%
Sell
0%

People also own

Based on the portfolios of people who own TECH. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.